Literature DB >> 25342609

Establishment of diagnostic reference levels in cardiac CT in France: a need for patient dose optimisation.

F Mafalanka1, C Etard2, J L Rehel1, D Pesenti-Rossi3, F Amrar-Vennier4, N Baron5, L Christiaens6, R Convers-Domart5, D Defez7, P Douek7, V Gaxotte8, J L Georges5, S Leygnac8, P Ou8, J L Sablayrolles9, C Salvat10, E Schouman-Claeys8, M Sirol10, B Aubert1.   

Abstract

The objective of this study was to propose diagnostic reference levels (DRLs) for coronary computed tomography angiography (CCTA), in the context of a large variability in patient radiation dose, and the lack of European recommendations. Volume Computed Tomography Dose Index (CTDIvol) and dose-length product (DLP) were collected from 460 CCTAs performed over a 3-month period at eight French hospitals. CCTAs (∼50 per centre) were performed using the routine protocols of the centres, and 64- to 320-detector CT scanners. ECG gating was prospective (n = 199) or retrospective (n = 261). The large gap in dose between these two modes required to propose specific DRLs: 26 and 44 mGy for CTDIvol, and 370 and 970 mGy cm for DLP, respectively. This study confirms the large variability in patient doses during CCTA and underlines the need for the optimisation of cardiac acquisition protocols. Availability of national DRLs should be mandatory in this setting.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 25342609     DOI: 10.1093/rpd/ncu317

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  7 in total

1.  Quantification of radiation dose reduction by reducing z-axis coverage in 320-detector coronary CT angiography.

Authors:  David J Murphy; Abhishek Keraliya; Nathan Himes; Ayaz Aghayev; Ron Blankstein; Michael L Steigner
Journal:  Br J Radiol       Date:  2017-06-14       Impact factor: 3.039

2.  Patient radiation biological risk in computed tomography angiography procedure.

Authors:  M Alkhorayef; E Babikir; A Alrushoud; H Al-Mohammed; A Sulieman
Journal:  Saudi J Biol Sci       Date:  2016-01-12       Impact factor: 4.219

3.  Assessment of Effective Dose Associated with Coronary Computed Tomography Angiography in Isfahan Province, Iran.

Authors:  Mohammadbagher Tavakoli; Reihane Faraji; Zahra Alirezaei; Zohre Nateghian
Journal:  J Med Signals Sens       Date:  2018 Jan-Mar

4.  In vitro optimization and comparison of CT angiography versus radial cardiovascular magnetic resonance for the quantification of cross-sectional areas and coronary endothelial function.

Authors:  Jérôme Yerly; Fabio Becce; Ruud B van Heeswijk; Francis R Verdun; Danilo Gubian; Reto Meuli; Matthias Stuber
Journal:  J Cardiovasc Magn Reson       Date:  2019-02-07       Impact factor: 5.364

5.  Establishment of diagnostic reference levels in cardiac computed tomography.

Authors:  Mohammad Rawashdeh; Charbel Saade; Maha Zaitoun; Mostafa Abdelrahman; Patrick Brennan; Haytham Alewaidat; Mark F McEntee
Journal:  J Appl Clin Med Phys       Date:  2019-08-30       Impact factor: 2.102

6.  Diagnostic reference levels and median doses for common clinical indications of CT: findings from an international registry.

Authors:  Denise Bos; Sophronia Yu; Jason Luong; Philip Chu; Yifei Wang; Andrew J Einstein; Jay Starkey; Bradley N Delman; Phuong-Anh T Duong; Marco Das; Sebastian Schindera; Allen R Goode; Fiona MacLeod; Axel Wetter; Rebecca Neill; Ryan K Lee; Jodi Roehm; James A Seibert; Luisa F Cervantes; Nima Kasraie; Pavlina Pike; Anokh Pahwa; Cécile R L P N Jeukens; Rebecca Smith-Bindman
Journal:  Eur Radiol       Date:  2021-10-13       Impact factor: 5.315

7.  CT imaging prior to transcatheter aortic valve implantation in the UK.

Authors:  Iwan Harries; Jonathan R Weir-McCall; Michelle C Williams; James Shambrook; Giles Roditi; Russel Bull; Gareth J Morgan-Hughes; Edward D Nicol; Alastair J Moss
Journal:  Open Heart       Date:  2020-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.